- Home
- Publications
- Publication Search
- Publication Details
Title
De novo design and optimization of Aurora A kinase inhibitors
Authors
Keywords
-
Journal
Chemical Science
Volume 4, Issue 3, Pages 1229
Publisher
Royal Society of Chemistry (RSC)
Online
2013-01-15
DOI
10.1039/c2sc21842a
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Drugs by Numbers: Reaction-Driven De Novo Design of Potent and Selective Anticancer Leads
- (2012) Birgit Spänkuch et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Thienopyridine ureas as dual inhibitors of the VEGF and Aurora kinase families
- (2012) Michael L. Curtin et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Probing the Bioactivity-Relevant Chemical Space of Robust Reactions and Common Molecular Building Blocks
- (2012) Markus Hartenfeller et al. Journal of Chemical Information and Modeling
- Finding the sweet spot: the role of nature and nurture in medicinal chemistry
- (2012) Michael M. Hann et al. NATURE REVIEWS DRUG DISCOVERY
- DOGS: Reaction-Driven de novo Design of Bioactive Compounds
- (2012) Markus Hartenfeller et al. PLoS Computational Biology
- Design, synthesis, and biological evaluation of pyrazolopyrimidine-sulfonamides as potent multiple-mitotic kinase (MMK) inhibitors (part I)
- (2011) Lin Zhang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Drug discovery in the next decade: innovation needed ASAP
- (2011) Youssef L. Bennani DRUG DISCOVERY TODAY
- Identifying Compound-Target Associations by Combining Bioactivity Profile Similarity Search and Public Databases Mining
- (2011) Tiejun Cheng et al. Journal of Chemical Information and Modeling
- Designing the molecular future
- (2011) Gisbert Schneider JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
- Aurora Kinase A expression is associated with lung cancer histological-subtypes and with tumor de-differentiation
- (2011) Marco Lo Iacono et al. Journal of Translational Medicine
- Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity
- (2011) Theonie Anastassiadis et al. NATURE BIOTECHNOLOGY
- The productivity crisis in pharmaceutical R&D
- (2011) Fabio Pammolli et al. NATURE REVIEWS DRUG DISCOVERY
- Thieno[3,2-c]pyrazoles: A novel class of Aurora inhibitors with favorable antitumor activity
- (2010) Simona Bindi et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Visualization of Molecular Selectivity and Structure Generation for Selective Dopamine Inhibitors
- (2010) Kiyoshi Hasegawa et al. Molecular Informatics
- Simple Size-Independent Measure of Ligand Efficiency
- (2009) J. Willem M. Nissink Journal of Chemical Information and Modeling
- The influence of lead discovery strategies on the properties of drug candidates
- (2009) György M. Keserü et al. NATURE REVIEWS DRUG DISCOVERY
- Expression of Aurora A (but Not Aurora B) Is Predictive of Survival in Breast Cancer
- (2008) Y. Nadler et al. CLINICAL CANCER RESEARCH
- Ligand Binding Efficiency: Trends, Physical Basis, and Implications
- (2008) Charles H. Reynolds et al. JOURNAL OF MEDICINAL CHEMISTRY
- Fragment-Based Discovery of the Pyrazol-4-yl Urea (AT9283), a Multitargeted Kinase Inhibitor with Potent Aurora Kinase Activity†
- (2008) Steven Howard et al. JOURNAL OF MEDICINAL CHEMISTRY
- Modulation of kinase-inhibitor interactions by auxiliary protein binding: Crystallography studies on Aurora A interactions with VX-680 and with TPX2
- (2008) Baoguang Zhao et al. PROTEIN SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search